Cochrane Evidence Synthesis and Methods ►

Tumor necrosis factor (TNF) inhibitors for the treatment of psoriatic arthritis

This is a protocol for a Cochrane Review (intervention). The objectives are as follows:

To assess the benefits and harms of TNF inhibitors in comparison with placebo and other treatment strategies in adult patients affected by psoriatic arthritis.

This is a protocol.

Health topics:

Rheumatology > Spondylo-arthropathy

Published:

14 May 2020

Authors:

Cagnotto G, Compagno M, Scire CAlberto, Bruschettini M

See the full Review on

the Cochrane Library

►

Was this helpful? Donate.

If you found this evidence helpful, please consider donating to Cochrane. We are a charity that produces accessible evidence to help people make health and care decisions.
Donate
Print
PDF
Citation
Cagnotto G, Compagno M, Scire CAlberto, Bruschettini M. Tumor necrosis factor (TNF) inhibitors for the treatment of psoriatic arthritis (Protocol). Cochrane Database of Systematic Reviews 2020, Issue 5. Art. No.: CD013614. DOI: 10.1002/14651858.CD013614.